The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Real-world cost-effectiveness of pertuzumab (P) with trastuzumab + chemo (T+Chemo) in patients (pts) with metastatic breast cancer (MBC): A population-based retrospective cohort study by the Canadian Real-world Evidence for Value in Cancer Drugs (CanREValue) collaboration.
 
Wei Fang Dai
No Relationships to Disclose
 
Jaclyn Marie Beca
No Relationships to Disclose
 
Chenthila Nagamuthu
No Relationships to Disclose
 
Ning Liu
No Relationships to Disclose
 
Maureen E. Trudeau
Stock and Other Ownership Interests - RNA Diagnostics
Research Funding - Astellas Pharma (Inst); AstraZeneca (Inst); Eisai (Inst); Genomic Health (Inst); Novartis (Inst); Pfizer (Inst); Roche Canada (Inst)
 
Craig Earle
No Relationships to Disclose
 
Claire De Oliveira
No Relationships to Disclose
 
Kelvin K. Chan
No Relationships to Disclose